与帕尼单抗相关的睫毛过长 - Suppr

Suppr

超能文献

Trichomegaly Associated with Panitumumab.

作者信息

Goyal Amrita, Blaes Anne

机构信息

University of Minnesota System, Minneapolis, MN

出版信息

N Engl J Med. 2020 Oct 15;383(16):e94. doi: 10.1056/NEJMicm2003622.

DOI:10.1056/NEJMicm2003622

PMID:33053288

Abstract

摘要

相似文献

Trichomegaly Associated with Panitumumab.

N Engl J Med. 2020 Oct 15;383(16):e94. doi: 10.1056/NEJMicm2003622.

Panitumumab-induced trichomegaly.

Curr Probl Cancer. 2021 Dec;45(6):100748. doi: 10.1016/j.currproblcancer.2021.100748. Epub 2021 Apr 23.

Hypertrichosis of the pinnae in a patient using panitumumab.

J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e277-e278. doi: 10.1111/jdv.14815. Epub 2018 Feb 15.

Trichomegaly Due to Panitumumab.

JAMA Dermatol. 2024 Jun 1;160(6):667. doi: 10.1001/jamadermatol.2024.0642.

Trichomegaly of the eyelashes induced by the epidermal growth factor receptor inhibitor cetuximab in the treatment of metastatic colorectal cancer.

BMJ Case Rep. 2019 Apr 30;12(4):e228968. doi: 10.1136/bcr-2018-228968.

Panitumumab-induced pulmonary toxicity.

Curr Oncol. 2019 Oct;26(5):e700-e702. doi: 10.3747/co.26.5399. Epub 2019 Oct 1.

Triad of trichomegaly, alopecia and male-pattern hair growth during treatment with erlotinib in non-small-cell lung cancer.

Ir J Med Sci. 2011 Mar;180(1):283-4. doi: 10.1007/s11845-009-0458-6. Epub 2010 Jan 28.

A case of trichomegaly of the eyelashes and facial hypertrichosis induced by erlotinib (Tarceva).

Int J Dermatol. 2009 Jan;48(1):97-8. doi: 10.1111/j.1365-4632.2009.03752.x.

Acquired trichomegaly: trichomegaly secondary to erlotinib.

JAMA Ophthalmol. 2014 Sep;132(9):1051. doi: 10.1001/jamaophthalmol.2014.545.

[Acquired trichomegaly and hypertrichosis].

J Fr Ophtalmol. 2014 Apr;37(4):339-41. doi: 10.1016/j.jfo.2014.01.002. Epub 2014 Feb 24.

引用本文的文献

Assessing clinical and morphological features of megalotrichosis induced by Tyrosine kinase inhibitors versus Prostaglandins analogues.

PLoS One. 2024 Dec 31;19(12):e0313326. doi: 10.1371/journal.pone.0313326. eCollection 2024.

Panitumumab-Induced Periorbital Dermatitis: A Case Report.

Clin Cosmet Investig Dermatol. 2024 Apr 3;17:763-767. doi: 10.2147/CCID.S459067. eCollection 2024.

Ocular Toxicity of Targeted Anticancer Agents.

Drugs. 2021 May;81(7):771-823. doi: 10.1007/s40265-021-01507-z. Epub 2021 Mar 31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Trichomegaly Associated with Panitumumab.

N Engl J Med. 2020 Oct 15;383(16):e94. doi: 10.1056/NEJMicm2003622.

Panitumumab-induced trichomegaly.

Curr Probl Cancer. 2021 Dec;45(6):100748. doi: 10.1016/j.currproblcancer.2021.100748. Epub 2021 Apr 23.

Hypertrichosis of the pinnae in a patient using panitumumab.

J Eur Acad Dermatol Venereol. 2018 Jul;32(7):e277-e278. doi: 10.1111/jdv.14815. Epub 2018 Feb 15.

Trichomegaly Due to Panitumumab.

JAMA Dermatol. 2024 Jun 1;160(6):667. doi: 10.1001/jamadermatol.2024.0642.

Trichomegaly of the eyelashes induced by the epidermal growth factor receptor inhibitor cetuximab in the treatment of metastatic colorectal cancer.

BMJ Case Rep. 2019 Apr 30;12(4):e228968. doi: 10.1136/bcr-2018-228968.

Panitumumab-induced pulmonary toxicity.

Curr Oncol. 2019 Oct;26(5):e700-e702. doi: 10.3747/co.26.5399. Epub 2019 Oct 1.

Triad of trichomegaly, alopecia and male-pattern hair growth during treatment with erlotinib in non-small-cell lung cancer.

Ir J Med Sci. 2011 Mar;180(1):283-4. doi: 10.1007/s11845-009-0458-6. Epub 2010 Jan 28.

A case of trichomegaly of the eyelashes and facial hypertrichosis induced by erlotinib (Tarceva).

Int J Dermatol. 2009 Jan;48(1):97-8. doi: 10.1111/j.1365-4632.2009.03752.x.

Acquired trichomegaly: trichomegaly secondary to erlotinib.

JAMA Ophthalmol. 2014 Sep;132(9):1051. doi: 10.1001/jamaophthalmol.2014.545.

[Acquired trichomegaly and hypertrichosis].

J Fr Ophtalmol. 2014 Apr;37(4):339-41. doi: 10.1016/j.jfo.2014.01.002. Epub 2014 Feb 24.

引用本文的文献

Assessing clinical and morphological features of megalotrichosis induced by Tyrosine kinase inhibitors versus Prostaglandins analogues.

PLoS One. 2024 Dec 31;19(12):e0313326. doi: 10.1371/journal.pone.0313326. eCollection 2024.

Panitumumab-Induced Periorbital Dermatitis: A Case Report.

Clin Cosmet Investig Dermatol. 2024 Apr 3;17:763-767. doi: 10.2147/CCID.S459067. eCollection 2024.

Ocular Toxicity of Targeted Anticancer Agents.

Drugs. 2021 May;81(7):771-823. doi: 10.1007/s40265-021-01507-z. Epub 2021 Mar 31.